在基于细胞的免疫疗法中寻找潜在的标,以应对急性髓性白血病的挑战
Amir Hossein Kheirkhah1, Sina Habibi2, Mohammad Hasan Yousefi1
1Department of Tissue Engineering and Applied Cell Sciences, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
Frontiers in immunology
|October 16, 2024
概括
基于细胞的创新免疫疗法,包括CAR-T细胞,TCR-T细胞和NK细胞疗法,在治疗急性髓性白血病 (AML) 中表现有前途. 这些先进的治疗方法旨在改善抗瘤免疫力和患者对抗这种具有挑战性的癌症的结果.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 尽管目前的治疗方法,急性髓性白血病 (AML) 存在高复发风险和低生存率.
- 对于新的治疗策略来改善AML患者的治疗结果至关重要.
研究的目的:
- 审查AML的基于细胞的免疫疗法的最新进展.
- 评估改善这些新疗法的疗效和安全性的机制,挑战和策略.
主要方法:
- 对AML的基于细胞的免疫疗法进行当前文献的全面审查.
- 对仿真抗原受体 (CAR) T 细胞疗法,T 细胞受体 (TCR) 设计的T 细胞疗法和基于自然杀手 (NK) 细胞的疗法的分析.
- 对目标抗原鉴定,毒性减轻和效应细胞增强的批判性评估.
主要成果:
- 基于细胞的免疫疗法为克服AML复杂性和异质性提供了有希望的途径.
- 战略正在发展,以提高这些治疗的疗效和安全性.
- 在翻译这些AML方法方面取得了重大进展.
结论:
- 基于细胞的免疫疗法是一个快速发展的领域,有可能为更有效和更持久的AML治疗提供机会.
- 目前正在进行的研究重点是优化标选择和改善免疫效应细胞功能.
- 这些创新方法对改善AML患者的治疗结果具有重大前景.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
4.1K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
